gilyard himself, along with the firm helped design bp's original settlement plan. >> we were involved international negotiations. we felt we were creating a butterfly, but it's been morphed into a buzzard. >> we were told that we weren't effected by the oil spill. we weren't a tourism related business because we were considered wholesale. their methodology was such we weren't considered tourism. we fought back to no avail. fine, we'll take your formula. >> they would appeal virtually everything ed. we had an appeal going up to the fifth circuit almost every two months. >> we were at the point we needed some relief. >> sure. >> and decided that was better than continuing to fight. we just fine. we'll take your number. >> then they ballked on that? >> they filed an appeal and stopped all of the process. since then it's now five years post oil spill and we're still waiting for the restitution. >> according to the official court authorized deep water horizon claims center, nearly 300,000 total claims have been submitted for economic and property damages from the spill. just over 80,000 cl

tdd# 1-800-345-2550 ♪ river shares of gilyard dropping.'s get to meg with the details. >> it's been a crazy after-hours session for gilead. a beat with $3.8 billion in revenue versus $3.5 billion for the estimate. also overall in revenue and eps for the quarter. but the guidance coming in a little bit conservative, which folks were potentially expecting. backing out from 26 to $27 billion in product sales, guided to looking at hepatitis c sales. compared to a $15 billion expectation from the street. so missing there. of course the big news is that gilead announcing its first dividend of 43 cents a share per quarter. and also a $15 billion buyback. so that's some big news. good for shareholders. but we're seeing the shares dropping as gilead is talking about the rebates its expects to be paying in 2015 for those big hepatitis c drugs. saying it's all tied to getting more access to the drugs, but looking at about a 46% gross to net adjustment for those drugs compared with about 22% in 2014. saying that's a result of a shift toward more publi

discounts for its hepatitis c drug overshadowing the announcement of gilyard's first ever dividend.he latest. plus news from wynn and disney. a market rally and a commodity comeback. oil closing on its highest level of the year today.